Yisheng Pharmaceutical (002566.SZ) released its report for the first quarter of 2024, achieving revenue of 200 million yuan during the reporting period...
According to the Zhitong Finance App, Yisheng Pharmaceutical (002566.SZ) released its report for the first quarter of 2024. During the reporting period, it achieved revenue of 200 million yuan, a year-on-year decrease of 20.16%. Net profit attributable to shareholders of listed companies was RMB 21.64 million, a year-on-year decrease of 26.78%. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was RMB 18.8948 million, a year-on-year decrease of 15.11%.